- Home
- PRTS vs ADVM Comparison
PRTS vs ADVM Comparison
Compare PRTS & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- ADVM
- Stock Information
- Founded
- PRTS 1995
- ADVM 2006
- Country
- PRTS United States
- ADVM United States
- Employees
- PRTS N/A
- ADVM N/A
- Industry
- PRTS Auto & Home Supply Stores
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRTS Consumer Discretionary
- ADVM Health Care
- Exchange
- PRTS Nasdaq
- ADVM Nasdaq
- Market Cap
- PRTS 47.8M
- ADVM 47.4M
- IPO Year
- PRTS 2007
- ADVM 2014
- Fundamental
- Price
- PRTS $0.92
- ADVM $2.83
- Analyst Decision
- PRTS Buy
- ADVM Strong Buy
- Analyst Count
- PRTS 2
- ADVM 5
- Target Price
- PRTS $1.40
- ADVM $26.40
- AVG Volume (30 Days)
- PRTS 652.3K
- ADVM 346.9K
- Earning Date
- PRTS 07-29-2025
- ADVM 05-14-2025
- Dividend Yield
- PRTS N/A
- ADVM N/A
- EPS Growth
- PRTS N/A
- ADVM N/A
- EPS
- PRTS N/A
- ADVM N/A
- Revenue
- PRTS $569,935,000.00
- ADVM $1,000,000.00
- Revenue This Year
- PRTS $1.73
- ADVM N/A
- Revenue Next Year
- PRTS $5.48
- ADVM $42.58
- P/E Ratio
- PRTS N/A
- ADVM N/A
- Revenue Growth
- PRTS N/A
- ADVM N/A
- 52 Week Low
- PRTS $0.68
- ADVM $1.78
- 52 Week High
- PRTS $1.45
- ADVM $10.14
- Technical
- Relative Strength Index (RSI)
- PRTS 56.09
- ADVM 55.73
- Support Level
- PRTS $0.85
- ADVM $2.37
- Resistance Level
- PRTS $0.94
- ADVM $2.63
- Average True Range (ATR)
- PRTS 0.05
- ADVM 0.20
- MACD
- PRTS 0.01
- ADVM 0.10
- Stochastic Oscillator
- PRTS 86.13
- ADVM 100.00
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.